Dose determination of VV116 in COVID-19 patients with severe liver dysfunction: a case report

Dose determination of VV116 in COVID-19 patients with severe liver dysfunction: a case report

VV116 is an oral antiviral drug against SARS-CoV-2, known for its favorable efficacy and safety profile. But its application in patients with severe liver dysfunction has not been evaluated. Here, we report a case in which a patient with aplastic anemia and liver impairment (recovery phase of acute...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Yang, Wenwen Jiang, Jianqing Deng, Min Liu, Ya Xue, Jizhang Bao, Tingting Jia, Qi Hu, Lichao Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Medicine
Subjects:
COVID-19
VV116
liver dysfunction
dosage adjustment
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1541235/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1541235/full

Similar Items